Safety and Efficacy of Monthly Long-acting IM Injection of 25mg or 40 mg GA Depot in Subjects With PPMS
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Primary Progressive Multiple Sclerosis
Related studies linked through entity extraction aliases.
Phase 1/2 Study to Evaluate the Safety and Efficacy of ATA188 in Subjects With Progressive Multiple Sclerosis
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Video Game-based Therapy for Arm Weakness In Progressive Multiple Sclerosis
- Status
- COMPLETED
- Phase
- NA
Dimethyl Fumarate Treatment of Primary Progressive Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE2
Mitochondrial Dysfunction and Disease Progression
- Status
- COMPLETED
- Phase
- N/A
A Phase 2 Clinical Study in Subjects With Primary Progressive Multiple Sclerosis to Assess the Efficacy, Safety and Tolerability of Two Oral Doses of Laquinimod Either of 0.6 mg/Day or 1.5mg/Day (Experimental Drug) as Compared to Placebo
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy, Safety and Tolerability of Andrographolides Versus Placebo in Patients With Progressive Forms of MS
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Phase 1 Trial of Intrathecal Rituximab for Progressive Multiple Sclerosis Patients
- Status
- COMPLETED
- Phase
- PHASE1
A Study of the Effectiveness of Fampridine in Improving Upper Limb Function in MS
- Status
- COMPLETED
- Phase
- PHASE4
Tear Analysis in the Diagnosis of Multiple Sclerosis
- Status
- COMPLETED
- Phase
- NA
ACTH in Progressive Forms of MS
- Status
- TERMINATED
- Phase
- PHASE2
Idebenone for Primary Progressive Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Serial Collection of Primary Progressive Multiple Sclerosis Participants in the MURDOCK Study
- Status
- COMPLETED
- Phase
- N/A
Safety Study of an Immunomodulating Microparticle to Treat Progressive Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Natalizumab Treatment of Progressive Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trial of Idebenone in Primary Progressive Multiple Sclerosis (IPPoMS)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
This Was an Open-label, Single-arm Extension Study (CFTY720D2306E1) to a Double-blind, Randomized Multicenter, Placebo-controlled, Parallel-group Core Study (CFTY720D2306) in PPMS.
- Status
- TERMINATED
- Phase
- PHASE3